0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Priorities for Lung Transplantation Among Patients With Cystic Fibrosis

Theodore G. Liou, MD; Frederick R. Adler, PhD; Barbara C. Cahill, MD; Stacey C. FitzSimmons, PhD; David Huang, DPH; Jonathan R. Hibbs, MD; Bruce C. Marshall, MD
JAMA. 2002;287(12):1523-1525. doi:10.1001/jama.287.12.1523.
Text Size: A A A
Published online

Extract

To the Editor: In her Editorial accompanying our article1 about prognostic factors for lung transplantation among patients with cystic fibrosis (CF), Dr Maurer2 noted that we did not comment on the survivorship effect of the rate of change in the FEV1%.

We, like others,35 initially made the logical assumption that patients with CF who have rapid deterioration of FEV1% would have an increased risk of death. It has been hypothesized that the subset of patients with the most rapid decline in FEV1% would gain a survival benefit from lung transplantation. We created theoretical survival models based on this hypothesis that suggested that we might be able to identify appropriate transplantation candidates several years before the optimal moment for transplantation. This would decrease the number of patients who die while on a waiting list, and optimize the use of donated organs. Unfortunately, none of these models are valid because we also found that the rate of decline in FEV1% is not a significant predictor of survival.6

Figures in this Article

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure. Relationship Between FEV1% Predicted Rate of Change, 1987-1992 and 1993-1997 [N = 12 477]
Graphic Jump Location

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 4

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();